Source:http://linkedlifedata.com/resource/pubmed/id/16276236
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2005-11-8
|
pubmed:abstractText |
Statins are widely prescribed and are established as first-line therapy for the primary and secondary prevention of coronary heart disease. Response to treatment varies considerably from person to person; however, inherited traits (genetic variability) may play a central role in this inter-individual variation. The purpose of this review is to summarize recent progress in the research for exploring genetic determinants of clinical efficacy and safety of statin therapy.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0957-9672
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
606-13
|
pubmed:meshHeading | |
pubmed:year |
2005
|
pubmed:articleTitle |
Statin pharmacogenomics: what have we learned, and what remains unanswered?
|
pubmed:affiliation |
Department of Cardiology, Kanazawa Medical University, Uchinada, Japan. kajinami@kanazawa-med.ac.jp
|
pubmed:publicationType |
Journal Article,
Review
|